Wiener Gesundheitsverbund - Klinik Hietzing 06 FE Study

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm	Enrolling by invitation	Phase 2	2026-07-28		NCT04093570

Clinical trials